Aortic stiffness, kidney disease, and renal transplantation

Sola Aoun Bahous1, Jacques Blacher, Michel E Safar

  • 1Diagnosis and Therapeutic Center, Hôpital Hôtel-Dieu, 1, Place du Parvis Notre-Dame, 75181 Paris Cedex 04, France.

Insights

High blood pressure in chronic kidney disease (CKD) patients accelerates kidney damage and cardiovascular risks. Managing systolic blood pressure is crucial for slowing disease progression and preventing major adverse events.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • High systolic blood pressure is a significant risk factor for chronic kidney disease (CKD) progression and cardiovascular (CV) events.
  • Aortic stiffness and reduced kidney function are closely linked, even independent of traditional CV risk factors.
  • Renal transplant recipients often exhibit increased aortic stiffness, influenced by donor age and acute rejection.

Purpose of the Study:

  • To investigate the relationship between aortic stiffness, renal function, and cardiovascular risk in various kidney disease populations.
  • To explore the impact of renal dysfunction on systemic pulse pressure and its transmission to the glomeruli.
  • To assess the potential of pharmacologic modulation of the renin-angiotensin system in end-stage renal disease (ESRD).

Main Methods:

  • Cross-sectional analysis of patients with mild to severe renal insufficiency.
  • Evaluation of aortic stiffness in renal transplant patients.
  • Observational study in subjects with end-stage renal disease and high CV risk.

Main Results:

  • Increased aortic stiffness correlates with reduced creatinine clearance in CKD patients.
  • Aortic stiffness is elevated in renal transplant patients, with donor age and rejection as contributing factors.
  • Renal dysfunction can lead to increased systemic pulse pressure, potentially damaging glomeruli and increasing CV events.

Conclusions:

  • Managing systolic blood pressure is vital for slowing CKD progression and reducing CV events.
  • Aortic stiffness is a key factor linking kidney disease and cardiovascular complications.
  • Targeting the renin-angiotensin system may offer a protective strategy for ESRD patients at high CV risk.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...